Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.

MLA

Guo, Kai, et al. “Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.” Journal of Clinical Endocrinology & Metabolism, vol. 107, no. 4, Apr. 2022, pp. 1091–109. EBSCOhost, https://doi.org/10.1210/clinem/dgab844.

APA

Guo, K., Savelieff, M. G., Rumora, A. E., Alakwaa, F. M., Callaghan, B. C., Hur, J., & Feldman, E. L. (2022). Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status. Journal of Clinical Endocrinology & Metabolism, 107(4), 1091–1109. https://doi.org/10.1210/clinem/dgab844

Chicago

Guo, Kai, Masha G. Savelieff, Amy E. Rumora, Fadhl M. Alakwaa, Brian C. Callaghan, Junguk Hur, and Eva L. Feldman. 2022. “Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.” Journal of Clinical Endocrinology & Metabolism 107 (4): 1091–1109. doi:10.1210/clinem/dgab844.